Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ANT activators(Adenine nucleotide translocase activators), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Rivus Pharmaceuticals, Inc.Startup |
Active Organization Rivus Pharmaceuticals, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Discovery | US | Rivus Pharmaceuticals, Inc.Startup | 14 Mar 2024 |